Vaxcyte Inc. Common Stock vs Constellation Brands Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while Constellation Brands Inc. Common Stock trades at $128.88 (market cap $21.50B). The key difference: Constellation Brands Inc. Common Stock is far larger — about 2× Vaxcyte Inc. Common Stock's market cap, and Constellation Brands Inc. Common Stock pays a 3.24% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals.
| PCVX | STZ | |
|---|---|---|
Market Cap | $10.51B | $21.50B |
Volume | 2,644,694 | 2,104,680 |
Sector | Health | Consumer Staples |
52-Week High | $73.82 | $166.68 |
52-Week Low | $40.32 | $112.77 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $9.14B | $31.72B |
Dividend Yield | — | 3.24% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Constellation Brands, Inc. is a US producer and marketer of beer, wine, and spirits, known for importing Mexican beer brands Corona and Modelo alongside a portfolio of wine and craft spirits labels.
Read more on STZ →